Editorial: NSAIDs Pharmacogenomics

José A G Agúndez; Christine Formea; Andrea Gaedigk; Elena García-Martín; Li Gong; Tilo Grosser; Craig R Lee; Katherine N Theken

doi:10.3389/fphar.2021.798447

Editorial: NSAIDs Pharmacogenomics

Front Pharmacol. 2021 Nov 19:12:798447. doi: 10.3389/fphar.2021.798447. eCollection 2021.

Authors

José A G Agúndez¹, Christine Formea², Andrea Gaedigk³, Elena García-Martín¹, Li Gong⁴, Tilo Grosser⁵, Craig R Lee⁶, Katherine N Theken⁵

Affiliations

¹ Universidad de Extremadura, Institute of Molecular Pathology Biomarkers, University of Extremadura, Cáceres, Spain.
² Intermountain Healthcare, Salt Lake City, UT, United States.
³ Children's Mercy, Kansas City, MO, United States.
⁴ Stanford University, Stanford, CA, United States.
⁵ University of Pennsylvania, Philadelphia, PA, United States.
⁶ University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.

No abstract available

Keywords: adverse drug effects; non-steroidal anti-inflammatory drug (NSAID); pharmacodynamic (PD); pharmacogenomics (PGx); pharmacokinectics & drug metabolism (PDM).

Publication types

Editorial